LIQUIDIA 106 Pill - purple clear capsule/oblong

Generic Name: treprostinil

Pill with imprint LIQUIDIA 106 is Purple / Clear, Capsule/Oblong and has been identified as Yutrepia 106 mcg (for oral inhalation). It is supplied by Liquidia Technologies, Inc.

Yutrepia is used in the treatment of Pulmonary Arterial Hypertension and belongs to the drug class agents for pulmonary hypertension. treprostinil (Remodulin, Tyvaso): There is no proven risk in humans during pregnancy. treprostinil oral (Orenitram): Risk cannot be ruled out during pregnancy. Yutrepia 106 mcg (for oral inhalation) is not a controlled substance under the Controlled Substances Act (CSA).

Images for LIQUIDIA 106

Yutrepia

Generic Name

treprostinil

Imprint

LIQUIDIA 106

Strength

106 mcg (for oral inhalation)

Color

Purple / Clear (opaque purple cap, clear body)

Shape

Capsule/Oblong (capsule)

Availability

Prescription only

Drug Class

Agents for pulmonary hypertension

Pregnancy Category

B - No proven risk in humans - treprostinil (Remodulin, Tyvaso), C - Risk cannot be ruled out - treprostinil oral (Orenitram)

CSA Schedule

Not a controlled drug

Labeler / Supplier

Liquidia Technologies, Inc.

National Drug Code (NDC)

72964-0014

Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer